Homy 2022 Annual Work Report

"Scarecrow Protection Project - FH Patient Information Registration"The project was officially launched on May 27, 2021, with the aim of gaining a deeper understanding of the current situation and needs of FH patients, understanding the effects of medication on FH patients and the possible side effects, and providing targeted long-term services for FH patients.

As of December 30, 2022, a total of 160 people had registered. This registration project is ongoing, and we hope more FH members will participate in our information registration project so that we can serve and help more FH members!

Children with high cholesterol (FH) cannot freely consume whole milk due to their extremely high cholesterol levels. Therefore, on July 21, 2021, we launched a [project/initiative/initiative].FH Children's Skim Milk Grant ProgramFifty children with familial disabilities (FH) were selected, and a case of skim milk was given to them every month for a year.

The project officially began purchasing and distributing skim milk in September 2021, and has now been distributed for 10 months, with 70 people receiving it each month, totaling 559 boxes of milk distributed. The project was originally scheduled to end in September 2022, but due to the impact of the pandemic, the distribution was not completed for a full year. We will make up for the shortfall in distribution later, and we apologize for any inconvenience caused.

This project aims to remind families of children with FH (figurine hepatitis B) to base their approach on dietary interventions, avoiding diets high in cholesterol and saturated fat, while also paying attention to the essential physical needs for growth and development in children. We hope all children grow up healthy and happy!

Blood Lipid Purification Funding ProjectLaunched on the same day as the skim milk project, the program primarily funded homozygous adults with fatty liver disease (FH). It provided subsidies of 3,000 yuan per treatment to 20 individuals, based on receipts for lipid-lowering treatments. The project lasted one year and has now ended.

In 2022, a total of 5 homozygous patients participated in this project, with a total of 10 reimbursements and a total funding amount of 28,000 yuan.